At first glance, a translation error in a patent may seem to be of little consequence, but a small such mistake in a patent owned by IBSA Institute Biochimique (IBSA) cost the company a lot to litigate. IBSA filed a petition for writ of certiorari in…
Read More
Read More
Apple Inc. has sued a former product designer for the company, claiming that he stole Apple trade secrets in order to help his new employer and that he also leaked secrets to a reporter. The designer, Simon Lancaster, worked at Apple for more than te…
Read More
Read More
We recently covered NFTs here, but due to the heightened interest regarding this topic, here’s a deeper dive into Non-fungible tokens (NFTs) that have taken the blockchain industry by storm. An NFT is a type of cryptocurrency asset wherein each ite…
Read More
Read More
The US Court of Appeals for the Federal Circuit has affirmed a district court’s grant of summary judgement of non-infringement in a case involving rival poultry chillers. The case of John Bean Technologies Corp. v. Morris & Associates, Inc. inv…
Read More
Read More
What’s a Non-Fungible Token (NFT) and is it a form of intellectual property (IP)? First, some background on NFTs. As the New York Times explains, An NFT is an asset verified using blockchain technology, in which a network of computers records trans…
Read More
Read More
An Inter Partes Review (IPR) is an administrative proceeding before a panel of Administrative Patent Judges at the Patent Trial and Appeal Board (PTAB or Board) – part of the United States Patent and Trademark Office (USPTO). The PTAB reviews wheth…
Read More
Read More
In this recent blog, we talked about the boom in blockchain-related patents, especially in China. But blockchain – and its most famous application, cryptocurrency (including Bitcoin) – isn’t the only area of financial innovation these days. Acc…
Read More
Read More
The licensing and royalty disputes between Samsung Electronics Co. and Ericsson Inc. have turned into a major legal fight across several jurisdictions. Each side has taken action in its bid to gain the upper hand. Analysts believe that this will even…
Read More
Read More
In January, the US Patent Office (USPTO) issued binding guidance that aligns the approach taken by the Patent Trial and Appeal Board (PTAB) with the approach of the federal courts on the issue of indefiniteness. 35 U.S.C. § 112(b) provides: The [pat…
Read More
Read More
Biotechnology and pharmaceutical companies spend billions of dollars annually in acquisitions, collaborations, and IP licensing agreements. These agreements lead to more innovations in terms of therapies and technologies to treat various illnesses an…
Read More
Read More